HK1250515A1 - 使用lgr4，lgr5和lgr6在组织应用中开发和使用最小极化功能细胞微集合体单元的方法 - Google Patents

使用lgr4，lgr5和lgr6在组织应用中开发和使用最小极化功能细胞微集合体单元的方法 Download PDF

Info

Publication number
HK1250515A1
HK1250515A1 HK18104680.7A HK18104680A HK1250515A1 HK 1250515 A1 HK1250515 A1 HK 1250515A1 HK 18104680 A HK18104680 A HK 18104680A HK 1250515 A1 HK1250515 A1 HK 1250515A1
Authority
HK
Hong Kong
Prior art keywords
applications
lgr4
lgr6
lgr5
development
Prior art date
Application number
HK18104680.7A
Other languages
English (en)
Chinese (zh)
Inventor
M. LOUGH Denver
Original Assignee
Polarityte, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1250515(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polarityte, Inc. filed Critical Polarityte, Inc.
Publication of HK1250515A1 publication Critical patent/HK1250515A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developmental Biology & Embryology (AREA)
HK18104680.7A 2014-12-02 2015-12-01 使用lgr4，lgr5和lgr6在组织应用中开发和使用最小极化功能细胞微集合体单元的方法 HK1250515A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US62/086,526 2014-12-02
US14/954,335 2015-11-30
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units
PCT/US2015/063114 WO2016089825A1 (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK19132587.7A Division HK40009324B (en) 2014-12-02 2018-04-10 Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK19132587.7A Addition HK40009324B (en) 2014-12-02 2018-04-10 Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Publications (1)

Publication Number Publication Date
HK1250515A1 true HK1250515A1 (zh) 2018-12-21

Family

ID=56078499

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104680.7A HK1250515A1 (zh) 2014-12-02 2015-12-01 使用lgr4，lgr5和lgr6在组织应用中开发和使用最小极化功能细胞微集合体单元的方法

Country Status (21)

Country Link
US (7) US10926001B2 (https=)
EP (2) EP4438128A3 (https=)
JP (3) JP6791854B2 (https=)
KR (5) KR20180136588A (https=)
CN (1) CN107250348B (https=)
AU (3) AU2015355187C1 (https=)
BR (1) BR112017011808A2 (https=)
CA (1) CA2969707C (https=)
CO (1) CO2017006640A2 (https=)
CR (1) CR20170296A (https=)
EA (1) EA201791125A1 (https=)
GB (2) GB2569056B (https=)
HK (1) HK1250515A1 (https=)
IL (2) IL252613B (https=)
MX (2) MX2017007243A (https=)
MY (1) MY184931A (https=)
NZ (2) NZ733433A (https=)
PH (1) PH12017501009B1 (https=)
SG (2) SG11201704502RA (https=)
WO (1) WO2016089825A1 (https=)
ZA (1) ZA201703907B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019010906A (es) * 2017-03-14 2020-02-12 Juno Therapeutics Inc Metodos para almacenamiento criogenico.
US20190231927A1 (en) * 2018-01-26 2019-08-01 Polarityte, Inc. Composite-interfacing biomaterial accelerant substrate
EP3743080A4 (en) * 2018-01-26 2021-10-27 Polarityte, Inc. SELF-ASSEMBLY MATERIALS COORDINATED WITH A COMPLEX LIVING INTERFACE (CLICSAM)
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025166131A1 (en) * 2024-02-01 2025-08-07 Board Of Regents, The University Of Texas System Compositions and methods for treating bone and muscle injuries

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (en) 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
US20060154365A1 (en) 2004-08-30 2006-07-13 Anthony Ratcliffe Cultured three dimensional tissues and uses thereof
BRPI0617818A2 (pt) 2005-10-27 2011-08-09 Coloplast As suporte polimérico biodegradável com material de ecm
EP2043731A4 (en) 2006-07-13 2010-07-21 St Jude Medical MEDICAL INFORMATION MANAGEMENT IN A PATIENT INFORMATION HUD SYSTEM
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
WO2008031767A1 (en) 2006-09-12 2008-03-20 Dkfz Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts Cell culture of keratinocytes under non-differentiating conditions
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
JP2012531185A (ja) 2009-06-25 2012-12-10 株式会社 資生堂 Ａｆｆ‐４を指標とした抗白髪剤のスクリーニング方法
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
JP6023049B2 (ja) 2010-06-30 2016-11-09 チェン，ジンシー 皮膚組織細胞の集合体の製造方法及びその用途
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
KR102025636B1 (ko) 2011-10-27 2019-11-04 우니베르지태트 라이치히 모낭 외모낭초로부터 멜라닌세포를 유도하기 위한 방법 및 이식을 위한 제조
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
PL2970890T3 (pl) 2013-03-14 2020-11-16 The Brigham And Women's Hospital, Inc. Kompozycje i sposoby ekspansji i hodowli nabłonkowych komórek macierzystych
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Also Published As

Publication number Publication date
SG10201914058QA (en) 2020-03-30
AU2019240603B2 (en) 2023-02-09
EP4438128A2 (en) 2024-10-02
IL252613A0 (en) 2017-07-31
MX2023001655A (es) 2023-04-24
JP6791854B2 (ja) 2020-11-25
GB201902819D0 (en) 2019-04-17
PH12017501009B1 (en) 2022-01-21
CA2969707C (en) 2019-08-20
US11000629B2 (en) 2021-05-11
AU2015355187B2 (en) 2019-10-03
GB2569056A (en) 2019-06-05
GB2549872A (en) 2017-11-01
US20220241464A1 (en) 2022-08-04
WO2016089825A1 (en) 2016-06-09
PH12017501009A1 (en) 2017-12-11
CA2969707A1 (en) 2016-06-09
EP3227431C0 (en) 2025-01-29
IL287488B2 (en) 2023-06-01
AU2015355187C1 (en) 2020-02-20
CN107250348A (zh) 2017-10-13
HK1245327A1 (zh) 2018-08-24
EP3227431A4 (en) 2019-01-02
JP2020182880A (ja) 2020-11-12
US20210322643A1 (en) 2021-10-21
GB2569056B (en) 2020-01-01
MY184931A (en) 2021-04-30
EP3227431B1 (en) 2025-01-29
KR20190111167A (ko) 2019-10-01
KR20210043024A (ko) 2021-04-20
CO2017006640A2 (es) 2017-11-21
CN107250348B (zh) 2021-09-03
AU2019240603A1 (en) 2019-10-17
NZ755260A (en) 2021-12-24
US20180154043A1 (en) 2018-06-07
AU2023202857A1 (en) 2023-05-25
NZ733433A (en) 2019-08-30
US20230181797A1 (en) 2023-06-15
EP4438128A3 (en) 2024-11-13
KR20180136587A (ko) 2018-12-24
SG11201704502RA (en) 2017-06-29
JP2019088299A (ja) 2019-06-13
ZA201703907B (en) 2023-03-29
US11596714B2 (en) 2023-03-07
US10926001B2 (en) 2021-02-23
AU2015355187A1 (en) 2017-06-29
GB201710646D0 (en) 2017-08-16
KR20170098844A (ko) 2017-08-30
MX2017007243A (es) 2018-01-25
IL287488A (en) 2021-12-01
IL252613B (en) 2021-12-01
US20180154044A1 (en) 2018-06-07
US11266765B2 (en) 2022-03-08
KR20180136588A (ko) 2018-12-24
US20190046691A1 (en) 2019-02-14
US20160151540A1 (en) 2016-06-02
JP2017538411A (ja) 2017-12-28
EA201791125A1 (ru) 2018-06-29
US11338060B2 (en) 2022-05-24
BR112017011808A2 (pt) 2018-02-27
CR20170296A (es) 2018-01-25
EP3227431A1 (en) 2017-10-11
US12465669B2 (en) 2025-11-11

Similar Documents

Publication Publication Date Title
PH12017501009A1 (en) Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
CY1125326T1 (el) Προαιρετικως συντηγμενα ετεροκυκλυλο- υποκατεστημενα παραγωγα πυριμιδινης χρησιμα για τη θεραπευτικη αγωγη φλεγμονωδων, μεταβολικων, ογκολογικων και αυτοανοσων ασθενειων.
CL2014000225A1 (es) Compuestos derivados de 1,2,4-triazol; composicion farmaceutica; procedimiento de preparacion de procursores de los mismos y el uso como moduladores del transporte nuclear en el tratamiento de enfermedades tales como cancer.
MX2022005955A (es) Metodos y composiciones para terapia celular adoptiva.
PH12015500115B1 (en) Glucagon analogues
MY187047A (en) Selective pyy compounds and uses thereof
BR112017016681A2 (pt) vetor de coexpressão de vacina e moléculas coestimulatórias
TW201613633A (en) Exendin-4 derivatives as selective glucagon receptor agonists
PH12018501237A1 (en) Isoindole compounds
BR112017028331A2 (pt) proteínas de fusão que se ligam a receptores fc humanos
EP3826625A4 (en) USE OF ANTI-CD5 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENE CELL THERAPY
BR112015007592A2 (pt) composições de enalapril
EA201691596A1 (ru) Составы гепарина для наружного применения
RU2726625C2 (ru) Фармацевтическая композиция, включающая полипептид
HK40009324B (en) Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
HK40009324A (en) Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
HK1236035A1 (en) Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases